Biotech Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights August 11, 2026
Biotech Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress August 10, 2026
Biotech Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027 August 10, 2026
Biotech Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company August 10, 2026
Biotech Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website August 6, 2026
Biotech Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases August 5, 2026
Biotech Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update August 5, 2026
Biotech Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program August 5, 2026
Biotech Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X August 5, 2026
Search
Biotech
August 11, 2026
August 11, 2026
August 10, 2026
August 10, 2026
August 10, 2026
August 6, 2026
August 5, 2026
August 5, 2026
August 5, 2026
August 5, 2026
